JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rady, J. J.
Right arrow Articles by Fujimoto, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rady, J. J.
Right arrow Articles by Fujimoto, J. M.

Vol. 284, Issue 3, 878-885, March 1998

Pentobarbital Antagonism of Morphine Analgesia Mediated by Spinal Cholecystokinin1

Jodie J. Rady, Wen Lin and James M. Fujimoto

Research Service, Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin

Pentobarbital administered intracerebroventricularly to mice has been shown previously to inhibit the analgesic action of morphine given intrathecally. The purpose of the present study was to examine the proposal that this antianalgesic action was mediated spinally by cholecystokinin. First, intrathecal coadministration of cholecystokinin-8 sulfate (CCK8s) with morphine inhibited the analgesic action of morphine in the mouse tail-flick test. This rightward shift of the morphine dose-response curve was reversed by the intrathecal administration of either the CCKA receptor antagonist, lorglumide, or the CCKB receptor antagonist, PD135,158. Second, lorglumide and PD135,158 given intrathecally also eliminated the antianalgesic effect of intracerebroventricularly administered pentobarbital against intrathecal morphine. Third, intrathecal pretreatment with CCK8 antiserum eliminated the effect of pentobarbital. Thus, the results indicated that pentobarbital antianalgesia was obtained through activation of a descending system to the spinal cord where cholecystokinin inhibited the spinal analgesic action of morphine.

0022-3565/98/2843-0878$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
J. J. Rady and J. M. Fujimoto
Confluence of Antianalgesic Action of Diverse Agents through Brain Interleukin1beta in Mice
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 659 - 665.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. J. Rady, B. B. Holmes, L. F. Tseng, and J. M. Fujimoto
Inverse Agonist Action of Leu-Enkephalin at delta 2-Opioid Receptors Mediates Spinal Antianalgesia
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 582 - 589.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. J. Rady, W. B. Campbell, and J. M. Fujimoto
Antianalgesic Action of Nociceptin Originating in the Brain Is Mediated by Spinal Prostaglandin E2 in Mice
J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 7 - 14.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.